...
首页> 外文期刊>Clinics and research in hepatology and gastroenterology. >Clinicopathological assessment of steatohepatitic hepatocellular carcinoma
【24h】

Clinicopathological assessment of steatohepatitic hepatocellular carcinoma

机译:

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

? 2021 The Author(s)Aim: To compare the clinicopathological features of typical steatohepatitic HCC (SH-HCC) with other HCCs. Methods: Subjects were 486 patients with untreated HCC who underwent hepatectomy at our hospital from January 2015 to December 2020. We compared patient backgrounds, preoperative laboratory data, imaging findings (ultrasonography, computed tomography CT, and magnetic resonance imaging MRI), and postoperative pathological findings (tumor and background of liver). The Liver Imaging Reporting And Data System (LI-RADS) was used to examine CT and MRI findings. Results: Typical SH-HCCs were significantly different from other HCCs with respect to age, hepatitis B virus (HBV) infection, and nonalcoholic steatohepatitis (NASH). Diabetes and hyperlipidemia were also significantly more common. Regarding histopathology, tumor size and background steatosis were significantly different between groups. Although ultrasonography, CT, and MRI could each alone diagnose SH-HCCs with a diameter < 20 mm in ≥ 50 of patients, the combined use of these tests improved diagnostic accuracy. By LI-RADS, 87 of SH-HCC cases were classified as LR-5, which are considered to be malignant tumors. Conclusions: It seems possible to diagnose SH-HCC by combining ultrasonography, CT, and MRI.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号